Technology Offerings

Ceramide C16:0 and Synthase 6 in Multiple Sclerosis Diagnosis

The C16:0-ceramide biomarkers described here, allow both the diagnosis and monitoring of autoimmune disease multiple sclerosis. Moreover the ceramide synthase 6 (CerS6) outlined in this invention serves as target for the treatment of MS.

Further Information: PDF

INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/2561632-0

Contact
Dr. Otmar Schöller

Comments (0)

Write a comment